Premium
Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

OTC - new therapeutic products in the U.S. 2012-2013

Percentage of new therapeutic OTC products in the U.S. in 2012-2013*

by Statista Research Department, last edited Aug 29, 2013
OTC - new therapeutic products in the U.S. 2012-2013 This statistic depicts the percentage of new therapeutic OTC (over-the-counter) products in the United States in 2012-2013 (June to June). In that time period, cough-cold/allergy products made over one third of all new therapeutic OTC products in the United States.
Show more

Percentage of new therapeutic OTC products in the U.S. in 2012-2013*

Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
Statista has been my savior on several occasions. The site is easy to maneuver and the data is in a format that can go right into a report or presentation.
Marlene Greenfield

Marlene Greenfield
Vice President, Hearst Magazines

Statistics on "Over-the-counter medicine industry in the United Kingdom"
  • Overview
The most important statistics
  • Pharmacy
  • Over-the-counter medication
  • Annual change in sales value
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.